First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
Saved in:
| Title: | First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens. |
|---|---|
| Authors: | Nyombayire J; Projet San Francisco, Kigali, Rwanda., Anzala O; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi., Gazzard B; Chelsea and Westminster Healthcare NHS Foundation Trust., Karita E; Projet San Francisco, Kigali, Rwanda., Bergin P; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Hayes P; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Kopycinski J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Omosa-Manyonyi G; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi., Jackson A; Chelsea and Westminster Healthcare NHS Foundation Trust., Bizimana J; Projet San Francisco, Kigali, Rwanda., Farah B; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi., Sayeed E; International AIDS Vaccine Initiative, New York, New York., Parks CL; International AIDS Vaccine Initiative, New York, New York., Inoue M; ID Pharma, Tsukuba., Hironaka T; ID Pharma, Tsukuba., Hara H; ID Pharma, Tsukuba., Shu T; ID Pharma, Tsukuba., Matano T; University of Tokyo.; National Institute of Infectious Diseases, Tokyo, Japan., Dally L; Emmes Corporation, Rockville, Maryland., Barin B; Emmes Corporation, Rockville, Maryland., Park H; International AIDS Vaccine Initiative, New York, New York., Gilmour J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Lombardo A; International AIDS Vaccine Initiative, New York, New York., Excler JL; International AIDS Vaccine Initiative, New York, New York., Fast P; International AIDS Vaccine Initiative, New York, New York., Laufer DS; International AIDS Vaccine Initiative, New York, New York., Cox JH; International AIDS Vaccine Initiative, New York, New York. |
| Corporate Authors: | S001 Study Team |
| Source: | The Journal of infectious diseases [J Infect Dis] 2017 Jan 01; Vol. 215 (1), pp. 95-104. Date of Electronic Publication: 2016 Oct 17. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28077588 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nyombayire+J%22">Nyombayire J</searchLink>; Projet San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Anzala+O%22">Anzala O</searchLink>; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi.<br /><searchLink fieldCode="AU" term="%22Gazzard+B%22">Gazzard B</searchLink>; Chelsea and Westminster Healthcare NHS Foundation Trust.<br /><searchLink fieldCode="AU" term="%22Karita+E%22">Karita E</searchLink>; Projet San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Bergin+P%22">Bergin P</searchLink>; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hayes+P%22">Hayes P</searchLink>; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kopycinski+J%22">Kopycinski J</searchLink>; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Omosa-Manyonyi+G%22">Omosa-Manyonyi G</searchLink>; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi.<br /><searchLink fieldCode="AU" term="%22Jackson+A%22">Jackson A</searchLink>; Chelsea and Westminster Healthcare NHS Foundation Trust.<br /><searchLink fieldCode="AU" term="%22Bizimana+J%22">Bizimana J</searchLink>; Projet San Francisco, Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Farah+B%22">Farah B</searchLink>; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi.<br /><searchLink fieldCode="AU" term="%22Sayeed+E%22">Sayeed E</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Parks+CL%22">Parks CL</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Inoue+M%22">Inoue M</searchLink>; ID Pharma, Tsukuba.<br /><searchLink fieldCode="AU" term="%22Hironaka+T%22">Hironaka T</searchLink>; ID Pharma, Tsukuba.<br /><searchLink fieldCode="AU" term="%22Hara+H%22">Hara H</searchLink>; ID Pharma, Tsukuba.<br /><searchLink fieldCode="AU" term="%22Shu+T%22">Shu T</searchLink>; ID Pharma, Tsukuba.<br /><searchLink fieldCode="AU" term="%22Matano+T%22">Matano T</searchLink>; University of Tokyo.; National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Dally+L%22">Dally L</searchLink>; Emmes Corporation, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Barin+B%22">Barin B</searchLink>; Emmes Corporation, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Gilmour+J%22">Gilmour J</searchLink>; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lombardo+A%22">Lombardo A</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Excler+JL%22">Excler JL</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Fast+P%22">Fast P</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Laufer+DS%22">Laufer DS</searchLink>; International AIDS Vaccine Initiative, New York, New York.<br /><searchLink fieldCode="AU" term="%22Cox+JH%22">Cox JH</searchLink>; International AIDS Vaccine Initiative, New York, New York. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22S001+Study+Team%22">S001 Study Team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2017 Jan 01; Vol. 215 (1), pp. 95-104. <i>Date of Electronic Publication: </i>2016 Oct 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28077588 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiw500 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 95 Titles: – TitleFull: First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nyombayire J – PersonEntity: Name: NameFull: Anzala O – PersonEntity: Name: NameFull: Gazzard B – PersonEntity: Name: NameFull: Karita E – PersonEntity: Name: NameFull: Bergin P – PersonEntity: Name: NameFull: Hayes P – PersonEntity: Name: NameFull: Kopycinski J – PersonEntity: Name: NameFull: Omosa-Manyonyi G – PersonEntity: Name: NameFull: Jackson A – PersonEntity: Name: NameFull: Bizimana J – PersonEntity: Name: NameFull: Farah B – PersonEntity: Name: NameFull: Sayeed E – PersonEntity: Name: NameFull: Parks CL – PersonEntity: Name: NameFull: Inoue M – PersonEntity: Name: NameFull: Hironaka T – PersonEntity: Name: NameFull: Hara H – PersonEntity: Name: NameFull: Shu T – PersonEntity: Name: NameFull: Matano T – PersonEntity: Name: NameFull: Dally L – PersonEntity: Name: NameFull: Barin B – PersonEntity: Name: NameFull: Park H – PersonEntity: Name: NameFull: Gilmour J – PersonEntity: Name: NameFull: Lombardo A – PersonEntity: Name: NameFull: Excler JL – PersonEntity: Name: NameFull: Fast P – PersonEntity: Name: NameFull: Laufer DS – PersonEntity: Name: NameFull: Cox JH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2017 Jan 01 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 215 – Type: issue Value: 1 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |
